Navigation Links
Can EUS elastography help distinguish benign from malignant tissue?
Date:4/15/2009

A major limitation of endoscopic ultrasound (EUS) examination is its limited capacity to determine the exact nature of a lesion. The differential diagnosis between benign and malignant lymph nodes and focal pancreatic masses based on the EUS appearance is difficult and frequently requires EUS-guided fine needle aspiration (EUS-FNA) for confirmation of malignancy. Elastography has recently been presented as a novel technique that can be applied during ultrasound (US) examination to assess and measure tissue elasticity. Knowing that malignant tissues are generally harder than normal surrounding tissue, elastography might provide interesting clinical information to help distinguish benign from malignant tissue based on their specific tissue consistency.

A research article to be published on April 7, 2009 in the World Journal of Gastroenterology addresses this question. A multicenter study was conducted and included 222 patients who underwent EUS examination with assessment of a pancreatic mass or lymph node. Knowing that malignant tissues are generally harder than normal surrounding tissue, elastography might provide interesting clinical information to help distinguish benign from malignant tissue based on their specific tissue consistency.

The sensitivity and specificity of EUS elastography to differentiate benign from malignant pancreatic lesions are 92.3% and 80.0%, respectively, compared to 92.3% and 68.9%, respectively, for the conventional B-mode images. The sensitivity and specificity of EUS elastography to differentiate benign from malignant lymph nodes was 91.8% and 82.5%, respectively, compared to 78.6% and 50.0%, respectively, for the B-mode images. The kappa coefficient is 0.785 for the pancreatic masses and 0.657 for the lymph nodes.

EUS elastography is superior compared to conventional B-mode imaging and appears able to distinguish benign from malignant pancreatic masses and lymph nodes with a high sensitivi-ty, specificity and accuracy. It might be reserved as a second line examination to help characterise pancreatic masses after negative EUS-FNA and might increase the yield of EUS-FNA for lymph nodes.


'/>"/>

Contact: Lin Tian
wjg@wjgnet.com
0086-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Related medicine news :

1. FDLI Names 2009 Distinguished Service and Leadership Award Recipients
2. Mouse model highlights histone methylation as distinguishing feature for leukemia subtypes
3. Mayo Clinic Announces 2008 Distinguished Alumni Awardees
4. Distinguishing Between Good and Bad Stress is Key for Leaders
5. Reeve Foundation Recruits Distinguished Stem-Cell Neurobiologist - The Salk Institutes Samuel L. Pfaff, Ph.D. - to its International Research Consortium
6. Distinguished Cardiologists and Scientists Honored With 2008 International Academy of Cardiology Award
7. URAC Reveals Distinguished Judges Panel for 2009 Best Practices in Health Care Consumer Empowerment and Protection Awards
8. AST Awards Richard N. Fine, M.D. 2008 Ernest Hodge Distinguished Achievement Award
9. LA BioMed investigator wins Distinguished Educator Award
10. USC physician Anne L. Peters receives American Diabetes Associations Distinguished Clinician Award
11. AACR CEO receives Distinguished Public Service Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... development of Physiocrine-based therapeutics to address severe, rare diseases, today announced ... upcoming BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay ... December 14, 2016, at 4:20 p.m. ET. About ... ...
(Date:12/9/2016)... , Dec. 9, 2016 Department of Health ... regulations for medical marijuana dispensaries under Act 16 are ... , and are now available online . ... in the plan for operation; process for dispensing medical ... well as where the dispensary facilities can be located," ...
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
Breaking Medicine Technology: